SightfileU.S. market data from official filings

Companies › TNYA

TENAYA THERAPEUTICS INC (TNYA)

Institutional ownership, SEC filings and insider activity

Sector: Healthcare & Pharma · SEC CIK 0001858848 · EDGAR filings · Updated 2026-07-14

TENAYA THERAPEUTICS INC (TNYA) has reported institutional ownership of 25.0%, with 103 institutional managers holding positions valued at $37.5M per the latest 13F reporting period. SEC filings include an active notice of delisting or failure to satisfy a continued listing rule (8-K Item 3.01).

Institutional ownership
25.0%
Institutional managers
103
Reported 13F value
$37.5M
Insider activity
39 trans.
−$5.97M net selling
Data flags
1 active
from SEC filings

Latest updates

Institutional ownership overview

According to SEC 13F filings tracked by Sightfile, TENAYA THERAPEUTICS INC has 103 institutional holders and institutional ownership of 25.0%.

Insider activity

Insiders reported 39 transactions (0 buys, 36 sells) across 5 reporting insiders, with a net reported value of −$5.97M.

Data flags from SEC filings

Active notice of delisting or failure to satisfy a continued listing rule (8-K Item 3.01), most recently filed 2026-01-30 (recurring since 2025-04-18) — source filing. The authoritative details are those stated in the filing itself.

Related companies

GALECTIN THERAPEUTICS (GALT) · AARDVARK THERAPEUTICS INC (AARD) · ACTUATE THERAPEUTICS INC (ACTU) · Cardiol Therapeutics Inc (CRDL) · BIOMEA FUSION INC (BMEA) · INSPIREMD INC (NSPR)

See full history, cross-references and alerts on Sightfile
Sightfile provides information only — not investment advice, recommendations, or an assessment of any security. Data is derived from official public sources (SEC EDGAR and U.S. government agencies), may contain errors or delays, and should be verified against the source filing before relying on it.
Data sources: SEC EDGAR (filings, 13F, FTD), aggregated by Sightfile. Page updated 2026-07-14.